| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Sodium picosulfate M1Z1 |
匹可硫酸鈉M1Z1 |
16985-05-0 |
詳細(xì)
|
| Deoxysepiapterin |
脫氧半胱氨酸 |
1797-87-1 |
詳細(xì)
|
| 3R, 5R epimer (impurity b) |
3R,5R差向異構(gòu)體（雜質(zhì)B） |
|
詳細(xì)
|
| Salkeliptin impurity k |
沙克列汀雜質(zhì)K |
|
詳細(xì)
|
| Salkeliptin impurity q |
沙克列汀雜質(zhì)Q |
|
詳細(xì)
|
| Omadacycline Impurity 3YWP-IM-03 |
奧瑪環(huán)素雜質(zhì)YWP-IM-03 |
2272886-35-6 |
詳細(xì)
|
| Amlodipine Impurity D |
氨氯地平雜質(zhì)D |
113994-41-5 |
詳細(xì)
|
| Levofloxacin Impurity D |
左氧氟沙星雜質(zhì)D |
178964-53-9 |
詳細(xì)
|
| Ceftriaxone EP impurity A |
頭孢曲松鈉EP雜質(zhì)A |
97164-54-0 |
詳細(xì)
|
| Bupropion Related Compound A HCl |
安非他酮雜質(zhì) A HCl |
1049718-72-0 |
詳細(xì)
|
| Nicergoline Impurity A |
尼麥角林EP雜質(zhì)A |
38536-28-6 |
詳細(xì)
|
| Linezolid ImpurityLNZA-E |
利奈唑胺雜質(zhì)LNZA-E |
1391068-25-9 |
詳細(xì)
|
| Calcium Levofolinate Impurity |
葉酸鈣雜質(zhì) |
39707-61-4 |
詳細(xì)
|
| Lysine Acetylsalicylate Impurity H |
賴氨匹林EP雜質(zhì)H |
121893-23-0 |
詳細(xì)
|
| formaldehyde O-methyl oxime |
O-甲基甲醛肟 |
62479-73-6 |
詳細(xì)
|
| Trimetazidine Impurity |
曲美他嗪亞硝胺雜質(zhì) |
92432-50-3 |
詳細(xì)
|
| Salkeliptin impurity b |
沙克列汀雜質(zhì)B |
|
詳細(xì)
|
| Salkeliptin impurity h |
沙克列汀雜質(zhì)H |
|
詳細(xì)
|
| Omadacycline Impurity 2YWP-IM-02 |
奧瑪環(huán)素雜質(zhì)YWP-IM-02 |
885112-31-2 |
詳細(xì)
|
| Tryptophan EP Impurity F |
色氨酸EP雜質(zhì)F |
145545-23-9 |
詳細(xì)
|
| Diltiazem EP Impurity B |
地爾硫卓EP雜質(zhì)B |
87447-47-0 |
詳細(xì)
|
| 5,6-trans Travoprost |
5,6-反式-曲伏前列素 |
1563176-59-9 |
詳細(xì)
|
| Afzosin hydrochloride impurity e |
鹽酸阿夫唑嗪雜質(zhì)E |
|
詳細(xì)
|
| Apatamide impurity 2 |
阿帕他胺雜質(zhì)2 |
133239-92-0 |
詳細(xì)
|
| Argatroban Impurity I |
阿加曲班雜質(zhì)I |
189264-02-6 |
詳細(xì)
|
| 2-Hydroxypropylcarbamate |
碳13尿 2-羥丙基氨基甲酸酯 |
17464-96-9 |
詳細(xì)
|
| Ilaprazole Impurity |
艾普拉唑雜質(zhì) |
1378653-43-0 |
詳細(xì)
|
| 3S, 5S epimer (impurity b) |
3S,5S差向異構(gòu)體（雜質(zhì)B） |
|
詳細(xì)
|
| Afzosin hydrochloride impurity a |
鹽酸阿夫唑嗪雜質(zhì)A |
|
詳細(xì)
|
| Salkeliptin impurity o |
沙克列汀雜質(zhì)O |
|
詳細(xì)
|
| Sugammadex Org226100-1 |
舒更葡糖鈉雜質(zhì)18 Org226100-1 |
2768160-22-9 |
詳細(xì)
|
| Vitamin K1 Impurity G |
維生素K1雜質(zhì)G |
34044-00-3 |
詳細(xì)
|
| 1-Propanol, 2-(2-hydroxypropoxy)-, 1-carbamate |
碳13尿 3-(2-羥基丙氧基)丙基氨基甲酸酯 |
2271317-97-4 |
詳細(xì)
|
| 1-hydroxypropyl-2-yl-Carbamate |
碳13尿 1-羥丙基-2-基-氨基甲酸酯 |
36473-03-7 |
詳細(xì)
|
| Linagliptin Impurity 106 |
利格列汀雜質(zhì)106 |
1955514-80-3 |
詳細(xì)
|
| Decarbamoylcefoxitin Cefoxitin Impurity E |
頭孢西丁雜質(zhì)E |
2395025-32-6 |
詳細(xì)
|
| Empagliflozin Impurity 25 |
恩格列凈雜質(zhì) 25 |
2452301-42-5 |
詳細(xì)
|
| Starting material II (impurity n) |
起始原料Ⅱ（雜質(zhì)N） |
|
詳細(xì)
|
| Salkeliptin impurity l |
沙克列汀雜質(zhì)L |
|
詳細(xì)
|
| Salkeliptin impurity r |
沙克列汀雜質(zhì)R |
|
詳細(xì)
|
| Omadacycline Impurity 1YWP-IM-01 |
奧瑪環(huán)素雜質(zhì)YWP-IM-01 |
601455-29-2 |
詳細(xì)
|
| Duloxetine Related Compound H |
鹽酸度洛西汀雜質(zhì)H |
199191-66-7 |
詳細(xì)
|
| Bupropion Related Compound B HCl |
安非他酮雜質(zhì) B HCl |
1049718-43-5 |
詳細(xì)
|
| Salbutamol Impurity L |
鹽酸左旋沙丁胺醇雜質(zhì)L |
149222-15-1 |
詳細(xì)
|
| Dapagliflozin peroxide impurit |
達(dá)格列凈過(guò)氧化物雜質(zhì) |
2452300-94-4 |
詳細(xì)
|
| Salkeliptin impurity c |
沙克列汀雜質(zhì)C |
|
詳細(xì)
|
| Salkeliptin impurity i |
沙克列汀雜質(zhì)I |
|
詳細(xì)
|
| 2-(((5-methoxy-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,5-dimethylpyridin-4(1H)-one |
艾司奧美拉唑雜質(zhì)5 |
301669-82-9 |
詳細(xì)
|
| (3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolyl]-3,5-dihydrosy-6-heptane acid,(+)phenyl ethylamine |
匹伐他汀雜質(zhì) |
147511-70-4 |
詳細(xì)
|
| Atorvastatin Impurity |
阿托伐他汀內(nèi)酰胺雜質(zhì) |
906552-18-9 |
詳細(xì)
|
| BOlmesartan Medoxomil EP Impurity B |
奧美沙坦酯脂EP雜質(zhì)B |
849206-43-5 |
詳細(xì)
|
| Ezetimibe tetrahydropyran Impurity 56 |
依折麥布四氫呋喃雜質(zhì)56 |
1296129-15-1 |
詳細(xì)
|
| Oseltamivir Impurity |
奧司他韋雜質(zhì) |
1415963-60-8 |
詳細(xì)
|
| Brexpiprazole Impurity |
二氫布瑞哌唑 |
913612-07-4 |
詳細(xì)
|
| Lubiprostone enantioMer Impurity |
蘆比前列酮對(duì)映異構(gòu)體 |
1217675-13-2 |
詳細(xì)
|
| Upadacitinib Impurity 15 |
烏帕替尼雜質(zhì)15 |
2304514-60-9 |
詳細(xì)
|
| Indapamide Impurity A |
吲達(dá)帕胺雜質(zhì)A |
85440-79-5 |
詳細(xì)
|
| Demethylation impurity |
脫甲基雜質(zhì) |
|
詳細(xì)
|
| Salkeliptin impurity e |
沙克列汀雜質(zhì)E |
|
詳細(xì)
|
| Salkeliptin impurity |
沙克列汀雜質(zhì) |
361442-04-8 |
詳細(xì)
|
| Levofloxacin N-oxide |
左氧氟沙星N-氧化物 |
117678-38-3 |
詳細(xì)
|
| Betahistine Impurity 9 |
倍他司汀雜質(zhì)9 |
6304-27-4 |
詳細(xì)
|
| Esomeprazole Impurity |
埃索美拉唑雜質(zhì) |
2362529-32-4 |
詳細(xì)
|
| Rosuvastatin tert butyl propionate (impurity f) |
瑞舒伐他汀丙叉叔丁酯（雜質(zhì)F） |
|
詳細(xì)
|
| Salkeliptin impurity m |
沙克列汀雜質(zhì)M |
|
詳細(xì)
|
| Paliperidone Impurity |
棕櫚酸帕利哌酮光降解雜質(zhì) |
913728-83-3 |
詳細(xì)
|
| Urea, N-(1-hydroxyethyl)- |
碳13尿 1-(2-羥丙基)脲 |
16395-94-1 |
詳細(xì)
|
| Sulbactam Impurity C |
舒巴坦雜質(zhì)C |
75527-87-6 |
詳細(xì)
|
| Afzosin hydrochloride impurity D |
鹽酸阿夫唑嗪雜質(zhì)D |
|
詳細(xì)
|
| Ticagrelor Impurity SIP-1 |
替格瑞洛雜質(zhì)SIP-1 |
2096989-56-7 |
詳細(xì)
|
| Mometasone Furoate EP Impurity H |
糠酸莫米松EP雜質(zhì)H |
148596-90-1 |
詳細(xì)
|
| Ethyl Lipoicate Impurity |
硫辛酸乙酯雜質(zhì) |
46353-61-1 |
詳細(xì)
|
| 1,1,5,5-Tetramethyl-2-(1-methylethenyl)cyclohexane |
1,1,5,5-四甲基-2-(1-甲基乙烯基)環(huán)己烷 |
63251-38-7 |
詳細(xì)
|
| Salkeliptin impurity d |
沙克列汀雜質(zhì)D |
|
詳細(xì)
|
| Salkeliptin impurity j |
沙克列汀雜質(zhì)J |
|
詳細(xì)
|
| Salkeliptin impurity p |
沙克列汀雜質(zhì)P |
|
詳細(xì)
|
| Linagliptin Impurity V |
利格列汀雜質(zhì) V |
2468656-63-3 |
詳細(xì)
|
| Omadacycline Impurity 6YWP-IM-06 |
奧瑪環(huán)素雜質(zhì)YWP-IM-06 |
488819-64-3 |
詳細(xì)
|
| Atorvastatin Calcium Impurity Ⅵ |
阿托伐他汀鈣雜質(zhì)VI降解物 |
873590-19-7 |
詳細(xì)
|
| Dapagliflozin Impurity A |
達(dá)格列凈雜質(zhì)A |
1373321-04-0 |
詳細(xì)
|
| Norepinephrine Impurity 9 |
去甲腎上腺素雜質(zhì)9 |
1891319-98-4 |
詳細(xì)
|
| Afzosin hydrochloride impurity |
鹽酸阿夫唑嗪雜質(zhì) |
81403-68-1 |
詳細(xì)
|
| Salkeliptin impurity f |
沙克列汀雜質(zhì)F |
|
詳細(xì)
|
| Salkeliptin impurity a |
沙克列汀雜質(zhì)A |
|
詳細(xì)
|
| Salkeliptin impurity g |
沙克列汀雜質(zhì)G |
|
詳細(xì)
|
| ValsartanEP Impurity A |
纈沙坦對(duì)映異構(gòu)體 |
137862-87-4 |
詳細(xì)
|
| Levonorgestrel Impurity 5 |
左炔諾孕酮雜質(zhì)5 |
17092-07-8 |
詳細(xì)
|
| Clavulanic acid Impurity C |
克拉維酸雜質(zhì)C |
86917-74-0 |
詳細(xì)
|
| Afzosin hydrochloride impurity B |
鹽酸阿夫唑嗪雜質(zhì)B |
|
詳細(xì)
|
| Cefaclor EP Impurity C |
頭孢克洛EP雜質(zhì)C |
143059-69-2 |
詳細(xì)
|
| Azacitidine α-Isomer Impurity |
阿扎胞苷a-異構(gòu)體雜質(zhì) |
157771-77-2 |
詳細(xì)
|
| Bisoprolol Hydroxyethyl Ester Impurity D |
比索洛爾羥乙酯雜質(zhì)D |
1346601-19-1 |
詳細(xì)
|
| Vonoprazan Impurity Imp-47 |
伏諾拉生雜質(zhì)Imp-47 |
2416241-97-7 |
詳細(xì)
|
| Amlodipine EP Impurity D |
氨氯地平EP雜質(zhì)D |
2138811-33-1 |
詳細(xì)
|
| Epalrestat (E,E)-Isomer |
依帕司他異構(gòu)體(E,E)對(duì)照品 |
863988-85-6 |
詳細(xì)
|
| DL-Pantothenic acid calcium salt |
DL泛酸鈣 |
6381-63-1 |
詳細(xì)
|
| Enantiomer (impurity g) |
對(duì)映異構(gòu)體（雜質(zhì)G） |
|
詳細(xì)
|
| Tert butyl rosuvastatin (impurity m) |
瑞舒伐他汀叔丁酯（雜質(zhì)M） |
|
詳細(xì)
|
| Salkeliptin impurity n |
沙克列汀雜質(zhì)N |
|
詳細(xì)
|